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ABSTRACT 
 
Varthemia persica DC. is an aromatic plant, from the Asteraceae family, wildly growing in the central provinces of 
Iran. Sesquiterpene lactones that are found in Varthemia species have protective effect against organophosphates 
toxicity. This study aimed to assess the Effect of Varthemia persica extract on acetylcholinesterase (AChE) activity. 
In this study, 0.4 mg normal saline was injected intra peritoneally in 12 control rats. 0.4 ml ethyl paraoxon was 
injected intraperitoneally in the reference group. In positive control group, after ethyl paraoxon injection, 0.4 ml 
pralidoxime was injected. In the first group (test 1) ethanolic Varthemia persica suspension was injected.  In the 
second group (test 2), during the 6 days before toxin injection, daily injection of Varthemia persica was made.  In 
test 3 group, suspension injection was repeated in 5 following days. In test 4 group, dichloroethanic suspension was 
injected. And in the last group (test 5) a high dose of suspension (1g/ml) was injected. The blood sample was 
collected 30 minutes after final injection. AChE activity was measure. The results showed that AChE activity was 
significantly improved only in the second and third groups and in other test groups, Varthemia persica suspension 
don’t improved AChE activity. Based on the present finding it seems that the Varthemia persica extract is only 
effective if it used frequently and a single dose even in high dose is not effective.  
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INTRODUCTION 
 
Throughout previous decades, organophosphates have been mostly used as insecticides and pesticides. Exposure to 
these products or their residues could cause acetylcholinesterase (AChE) inhibition and neurodevelopmental 
consequences including smaller head circumference [1] and more abnormal primitive reflexes [2]. AChE is an 
enzyme responsible for termination of impulse transmission via degrading of the excitatory neurotransmitter, 
acetylcholine (ACh) [3]. The toxicity of organophosphorus (OP) is capable of inhibiting AChE irreversibly, forming 
a bond with a serine remainder at the active site [4]. There are therapeutic regimes for organophosphate toxicity 
including muscarinic receptor antagonists and ACHE reactivators [5]. 
 
Medicinal plants are a key resource for discovering new drugs [6-9]. They have been used in traditional medicine for 
prevention of human disorders [10-17]. Also the effects of them have been investigated in a lot of studies [18-24]. 
They have been shown the antioxidant activity, anti-inflammatory, anti-hyperlipidemic effects, etc. In this regards, 
Varthemia persica DC. is an aromatic plant, from the Asteraceae family, wildly growing in the central provinces of 
Iran [25]. Phenolic compounds and coumarin are the most efficient component of this plant [26]. The essential oil of 
this plant has several terpenoid including monoterepens (3.28%), sesquiterpens (44.91%), oxygenated 
sesquiterepens (36.49%) and oxygenated monoterpens (1.82%) [27]. Sesquiterpene lactones that are found in 
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Varthemia species have protective effect against organophosphates toxicity [28]. A previous study on aerial parts of 
Varthemia persica identified numbers of volatile oil components including β-Eudesmol [27]. Moreover, the 
protective effect of β-Eudesmol on anti-cholinesterase organophosphorus evaluated and it has been shown that β-
Eudesmol boost isopropyl fluoro phosphate [29]. However to the best of our knowledge there is no study evaluating 
the effect of Varthemia persica extract on cholinesterase, so this study aimed to assess the effect of Varthemia 
persica extract on acetylcholinesterase activity. 
 
MATERIALS AND METHODS  
 
Wild Varthemia persica DC was collected from the high mountains of Natanz, Iran during September and dried in 
shadow and Lab temperature before extraction. 100 grams of dried plant were re-dissolved with one litter of 
methanol and dichloromethane for 48 hours. The solution was filtered with filter paper and then concentrated with 
rotary in 40 degree centigrade. To produce 250mg/dl stable suspension for injection, 4 grams of this extract, 0.5 
milliliter tween and 19.5 milliliter normal saline were used.  
 
Adult female rats (200-225 g) were kept at 32±2ºC with the 12 hours daily light-dark cycle. 12 samples were entered 
in the control group and 0.4 mg normal saline was injected intraperitoneally. 0.4 ml ethyl paraoxon was injected 
intraperitoneally in the reference group. In positive control group, one minute after ethyl paraoxon injection, 0.4 ml 
pralidoxime 0.125 molar in normal saline was intraperitoneally injected.  In the first group (test 1) 0.4 ml ethanolic 
Varthemia persica suspension (250mg/dl) was injected (one minutes after paraoxon injection).  In the second group 
(test 2), during the 6 days before toxin injection, daily injection of Varthemia persica suspension was made.  In test 
3 group, one minute after the toxin injection the Varthemia persica suspension was injected and the suspension 
injection was repeated in 5 following days. In test 4 group, dichloroethanic suspension was injected (one minute 
after paraoxon injection). And in the last group (test 5) a high dose of suspension (1g/ml) was injected. The blood 
sample was collected 30 minutes after final injection. 
 
Blood samples were collected at -20°C until being assayed. AChE activity was measured with a 
spectrophotometer at 436 nm and total hemoglobin concentration was measured with spectrophotometer at 546 nm. 
AChE activity and specific Activity of AChE was calculated by equations [30]. 
 
Statistical analyses were achieved using SPSS 15 software. Analysis of variance (ANOVA) was used to compare 
means of enzyme activity between tests and references groups. 
 
RESULTS AND DISCUSSION 
 
In this study the effect of different treatment with of Varthemia persica extract on acetylcholinesterase activity was 
assessed. The result showed a significant improvement after injection of 0.4 ml ethanolic Varthemia persica 
suspension (250 mg/dl) repeatedly before or after toxin injection in comparison with reference group.  
 
Table 1 shows acetyl cholinesterase activity in different groups in comparison with reference group (ethyl 
paraoxon). After injection of toxin AChE activity significantly decreased (more than 5 µmol/l.min). Pralidoxime 
significantly improved AChE activity (from 1.19 to 4.34 µmol/l.min). Compared with those receives the only toxin, 
in control group, positive control group and group 2 that received daily injection of Varthemia persica during the 6 
days before toxin injection and group 3 that received Varthemia persica suspension  repeatedly in 5 following days, 
AChE activity was significantly improved. The same results was observed for specific activity of AChE (table 2). 
 
Table 1: AChE Activity in different groups 
 
Groups n AChE Activity 
(µmol/l.min) 
Control 12 6.46±2.31* 
Reference  12 1.19±0.73 
Positive control 6 4.34±1.01* 
Test 1  12 1.17±1.16 
Test 2 6 2.05±0.90* 
Test 3 6 1.77±0.76* 
Test 4 6 1.05±0.41 
Test 5 6 0.81±0.85 
Data (AChE Activity) has been shown as mean ± SD; * Significant difference with reference group (P<0.05). 
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Table 2: Specific Activity of AChE in different groups 
 
Groups n Specific activity of AChE (µmol/l.min) 
Control 12 0.0074±0.0026* 
Reference  12 0.0014±0.0009 
Positive control 6 0.0045±0.0007* 
Test 1  12 0.0013±0.0013 
Test 2 6 0.0022±0.0009* 
Test 3 6 0.0019±0.0007* 
Test 4 6 0.0011±0.0004 
Test 5 6 0.0009±0.0009 
Data (Specific activity of AChE) has been shown as mean ± SD; * Significant difference with reference group (P<0.05). 
 
Organophosphorus pesticides are available worldwide in agriculture and household gardens to use as insecticides 
and cause public-health problem across much of rural Asia [31]. OP as an irreversible cholinesterase inhibitors 
inhibit acetylcholinesterase activities and cause accumulation of ACh at synapses, and trouble of neurotransmission 
in nervous systems [32]. The most common reported symptoms are vomiting, abdominal pain, hypersalivation, 
respiratory distress, and low level of consciousness and muscle twitch [33]. Despite the severity and require 
intensive care management, diagnosis and suitable treatment are often lifesaving [34]. In treating sever or moderate 
OP toxicity oximes are supposed to be effective, and mostly used [32]. Sodium bicarbonate is sometimes used in 
place of oximes for treatment of OP poisoning in Iran [35]. Beta-eudesmol, existing in Chinese herb antagonizes 
toxicity of organophosphate, reduce the incidence of convulsions and reverse the neuromuscular failure [36]. Beta-
eudesmol (31.7%) was detected from Water extracted essential oil from Varthemia persica aerial parts [37]. 
Eudesmol, a sesquiterpenol present in Varthemia persica has a protective effect against organophosphates toxicity 
[38].  
 
In the current study we used different treatment with ethanolic Varthemia persica suspension on the AChE activity 
as a marker for OP poisoning and found that a single dose of this suspension is not effective on AChE activity, 
however repeated dose before or after the ethyl paraoxon injection significantly improved its activity. The 
mechanism by which just repeated doses are effective is not clear. However, it has been shown that the plants with 
phenolic compounds have antioxidant activities [39-57], and antioxidants, in some cases, have different or 
paradoxical responses [58-65], which worth examining their mechanism actions. 
   
CONCLUSION 
 
Based on the present finding it seems that the Varthemia persica extract is only effective if it is used frequently and 
a single dose even in high dose is not effective.  
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